Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

83512 Press Releases
DateTitleCompany
30 Jul 15 Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients Daiichi Sankyo Europe; Plexxikon Inc.,
Published by
PR Newswire
30 Jul 15 Genkyotex’s NOX1&4 Inhibitor Strategy in Liver Fibrosis Supported by New Preclinical Results Genkyotex,
Published by
Business Wire
30 Jul 15 The 26th Neuronal Plasticity Prize of the Fondation Ipsen has been awarded to Fondation Ipsen,
Published by
Business Wire
30 Jul 15 Novare Pharmaceuticals Announces the Issuance of a U.S. patent for its RHAMM-Binding Peptides Novare Pharmaceuticals,
Published by
Business Wire
30 Jul 15 TiGenix: TiGenix expands pipeline and enters the cardiology field with clinical-stage company acquisition Published by
GlobeNewswire
30 Jul 15 TiGenix: TiGenix expands pipeline and enters the cardiology field with clinical-stage company acquisition TiGenix,
Published by
GlobeNewswire
30 Jul 15 Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players Mordor Intelligence LLP,
Published by
PR Newswire
30 Jul 15 Kiadis Pharma Announces Full Enrolment of its Phase II Clinical Study with Lead Product, ATIR101™ Kiadis Pharma,
Published by
Business Wire
30 Jul 15 vTv Therapeutics Inc. Announces Pricing of Initial Public Offering vTv Therapeutics Inc.,
Published by
Business Wire
30 Jul 15 Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock Published by
GlobeNewswire
30 Jul 15 EnLyte Monotherapy Reduces Toxic Homocysteine in Patients With MTHFR Polymorphism: Breakthrough Study Shows Significant Reduction In Toxic Amino Acid Linked To Hundreds Of Diseases Published by
GlobeNewswire
30 Jul 15 New Study Shows Homocysteine Reduction Directly Correlates With Higher Remission Rates in Depression Published by
GlobeNewswire
30 Jul 15 New Study Proves Homocysteine Theory of Depression: Lower Homocysteine, Achieve Higher Remission Rates in Major Depressive Disorder Published by
GlobeNewswire
30 Jul 15 JayMac Pharmaceuticals Launches EnBrace HR: A Unique New Prenatal For High Risk Pregnancy Published by
GlobeNewswire
30 Jul 15 Breakthrough Depression Study Shows 42% Remission Rate With EnLyte Published by
GlobeNewswire
30 Jul 15 AMAG Pharmaceuticals Announces Proposed Public Offering of $200 Million of Common Stock Published by
GlobeNewswire
30 Jul 15 Teleflex Signs New Agreement With HealthTrust For Port Closure Products Teleflex Incorporated,
Published by
Business Wire
30 Jul 15 Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. Bristol-Myers Squibb Company,
Published by
Business Wire
30 Jul 15 Dicerna to Announce Second Quarter 2015 Financial Results and Host Conference Call on August 6, 2015 Dicerna Pharmaceuticals, Inc.,
Published by
Business Wire
29 Jul 15 Vitae Pharmaceuticals Appoints Dr. John M. Leonard to Board of Directors Published by
GlobeNewswire
29 Jul 15 Galapagos' selective JAK1 inhibitor filgotinib meets key efficacy endpoints, shows ACR70 responses up to 39%, and maintains safety profile after 24 weeks of treatment in DARWIN 1 Phase 2B study Published by
GlobeNewswire
29 Jul 15 Tetraphase to Host Conference Call on August 5th to Discuss Second Quarter 2015 Financial Results Published by
GlobeNewswire
29 Jul 15 TRACON to Report Second Quarter 2015 Company Highlights and Financial Results on August 5, 2015 Published by
GlobeNewswire
29 Jul 15 MacroGenics Announces Date of Second Quarter 2015 Financial Results Conference Call Published by
GlobeNewswire
29 Jul 15 Intercept to Report Second Quarter 2015 Financial Results on August 5 and Present at Upcoming Conferences Published by
GlobeNewswire
29 Jul 15 TriVascular Technologies, Inc. to Present at the Canaccord Genuity Growth Conference Published by
GlobeNewswire
29 Jul 15 Flexion Therapeutics Completes Enrollment in Phase 3 Clinical Trial With Lead Compound FX006 in Patients With Osteoarthritis of the Knee Published by
GlobeNewswire
29 Jul 15 Galapagos' selective JAK1 inhibitor filgotinib meets key efficacy endpoints, shows ACR70 responses up to 39%, and maintains safety profile after 24 weeks of treatment in DARWIN 1 Phase 2B study Galapagos NV,
Published by
GlobeNewswire
29 Jul 15 Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients Daiichi Sankyo, Inc.; Plexxikon Inc.,
Published by
PR Newswire
29 Jul 15 Ascendis Pharma A/S to Report Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone and Host Conference Call on Thursday, July 30, 2015 at 9:00 a.m. Eastern Time Ascendis Pharma A/S,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.